Amivantamab: Phase III MARIPOSA-2 combo vs chemotherapy in EGFR-mutated advanced NSCLC Non-Small Cell Lung Cancer 2 Mins Read36 By. Antonio Passaro, MDDate. October 31, 2023Antonio Passaro, MD, an oncologist specializing in lung cancer, has been deeply involved in…
